These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16029937)

  • 41. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
    Wolf LA; Terry PD; Potter JD; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy use and the risk of stroke.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tibolone for prevention and treatment of postmenopausal osteoporosis.
    Ettinger B
    Maturitas; 2007 May; 57(1):35-8. PubMed ID: 17350774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
    Mittal K; Da Costa D
    Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
    Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cervical polyps in postmenopausal women: is there a difference in risk?
    Schnatz PF; Ricci S; O'Sullivan DM
    Menopause; 2009; 16(3):524-8. PubMed ID: 19179926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
    Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tubulo-squamous polyp: a report of ten cases of a distinctive hitherto uncharacterized vaginal polyp.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2007 Jul; 31(7):1013-9. PubMed ID: 17592267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.
    Veronesi U; Maisonneuve P; Rotmensz N; Bonanni B; Boyle P; Viale G; Costa A; Sacchini V; Travaglini R; D'Aiuto G; Oliviero P; Lovison F; Gucciardo G; del Turco MR; Muraca MG; Pizzichetta MA; Conforti S; Decensi A;
    J Natl Cancer Inst; 2007 May; 99(9):727-37. PubMed ID: 17470740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Side effects of therapy: case 2. Tamoxifen and uterine abnormalities.
    Buijs C; Willemse PH; Tinga DJ; Hollema H; de Vries EG; Mourits MJ
    J Clin Oncol; 2004 Jun; 22(12):2505-7. PubMed ID: 15197214
    [No Abstract]   [Full Text] [Related]  

  • 54. Controversies regarding hormone therapy: Insights from inflammation and hemostasis.
    Koh KK; Yoon BK
    Cardiovasc Res; 2006 Apr; 70(1):22-30. PubMed ID: 16412400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.
    Rieck GC; Freites ON; Williams S
    J Obstet Gynaecol; 2005 Jan; 25(1):39-41. PubMed ID: 16147692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
    Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
    Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hormone treatment on hemostasis variables.
    Kluft C
    Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
    Verheul HA; Blok LJ; Burger CW; Hanifi-Moghaddam P; Kloosterboer HJ
    Reprod Sci; 2007 Feb; 14(2):160-8. PubMed ID: 17636227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
    Osmanağaoğlu MA; Atasaral T; Baltaci D; Bozkaya H
    Climacteric; 2006 Dec; 9(6):464-72. PubMed ID: 17085380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.